On the value of the activated clotting time for monitoring heparin therapy in acute coronary syndromes
Authors:
- Angelo BranziABAngelo Branzi
- Anna Maria TrainiATAnna Maria Traini
- Franco SempriniFSFranco Semprini
- Vittorio CerviVCVittorio Cervi
- Bruno MagnaniBMBruno Magnani
- 1 February 1993
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 71 (5) , 469-471
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial.Heart, 1992
- Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo.Circulation, 1992
- HeparinNew England Journal of Medicine, 1991
- A Comparison between Heparin and Low-Dose Aspirin as Adjunctive Therapy with Tissue Plasminogen Activator for Acute Myocardial InfarctionNew England Journal of Medicine, 1990
- Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparin.Heart, 1990
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable anginaThe Lancet, 1990
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Insights into the pathogenesis of acute ischemic syndromes.Circulation, 1988
- Statistical Correlation and Heparin Sensitivity of Activated Partial Thromboplastin Time, Whole Blood Coagulation Time, and an Automated Coagulation TimeAmerican Journal of Clinical Pathology, 1973